Drug · DIN 02402246
AJ-ADENOSINE
2 ML SINGLE-USE VIAL
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since November 3, 2015.
- Drug Identification Number (DIN)
- 02402246
- Company (DIN owner)
- Agila Jamp Canada IncEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Adenosine C01EB10
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADENOSINE | 3 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 22, 2013: NOC 14152Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named AJ-ADENOSINE
- DIN 02410559 · Cancelled Pre Market